Individualizing renal cell carcinoma treatment through biomarkers discovery in the era of immune checkpoint inhibitors: where do we stand?-Reference-Cited by-同舟云学术

Individualizing renal cell carcinoma treatment through biomarkers discovery in the era of immune checkpoint inhibitors: where do we stand?

Published:2021-03-11 Issue:3 Volume:31 Page:236-241
ISSN:0963-0643
Container-title:Current Opinion in Urology
language:en
Short-container-title:

Author:

Porta Camillo,Cosmai Laura,Rizzo Mimma

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference38 articles.

1. NCCN guidelines insights: kidney cancer, version 1.2021;Motzer;J Natl Compr Canc Netw,2020

2. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018

3. Combined blockade of vascular endothelial growth factor and programmed death 1 pathways in advanced kidney cancer;Einstein;Clin Adv Hematol Oncol,2017

4. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Rini;N Engl J Med,2019

5. Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: first results from the randomized phase III CheckMate 9ER trial;Choueiri;Ann Oncol,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research;Clinical Genitourinary Cancer;2023-08

2. An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study;ESMO Open;2023-08

3. The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs;Journal of Translational Medicine;2022-08-16

4. Editorial: Standard and future in the treatment of renal cell carcinoma;Current Opinion in Urology;2021-05

5. Recent advances in the frontline treatment of metastatic renal cell carcinoma;Journal of Cancer Metastasis and Treatment;2021